
Hyloris Pharmaceuticals SA
HYL | BR
Overview
Corporate Details
- ISIN(s):
- BE0974363955
- LEI:
- 875500LZIWS7QEQE0I73
- Country:
- Belgium
- Address:
- Boulevard de Patience et Beaujonc 3, 4000 Liège
- Website:
- https://hyloris.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
We are a specialty biopharma company committed to bringing innovative, value-added medicines that address the needs of underserved patient populations. We apply our knowhow and technological innovations to existing pharmaceuticals to unlock their hidden potential and address unmet medical needs. We have built a broad proprietary pipeline of complex value-added products with potential to offer significant advantages over currently available alternatives. Today, we have two, partnered commercial-stage products, Sotalol IV for the treatment of atrial fibrillation, and Maxigesic® IV, a novel, dual mode-of-action non-opioid analgesic for the treatment of post-operative pain. Our development strategy of reformulating and repurposing approved pharmaceuticals primarily utilises the 505(b)(2) regulatory pathway in the U.S. and similar pathways in other countries, which are specifically designed for pharmaceutical agents for which the safety and efficacy have already been established.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-06-23 07:00 |
Regulatory News Service
PR Hyloris_Kuvatris Therapeutics_Partnership EN.pdf
|
English | 251.4 KB | |
2025-06-23 07:00 |
Regulatory News Service
PR Hyloris_Kuvatris Therapeutics_Partenariat FR.pdf
|
French | 289.9 KB | |
2025-06-10 20:00 |
Declaration of Voting Results & Voting Rights Announcements
PR AGM 2025 - Hyloris EN.pdf
|
English | 140.7 KB | |
2025-06-10 20:00 |
Declaration of Voting Results & Voting Rights Announcements
PR AGM 2025 - Hyloris FR.pdf
|
French | 173.5 KB | |
2025-06-10 20:00 |
General Meeting Notice
Minutes Ordinary General Shareholders Meeting_ENG_10 June 2025.pdf
|
English | 3.9 MB | |
2025-06-10 20:00 |
General Meeting Notice
Minutes Ordinary General Shareholders Meeting_FR_10 June 2025.pdf
|
French | 3.9 MB | |
2025-05-22 07:00 |
Regulatory News Service
PR XTRAZA with AFT_En.pdf
|
English | 118.3 KB | |
2025-05-22 07:00 |
Regulatory News Service
PR XTRAZA with AFT_FR.pdf
|
French | 160.5 KB | |
2025-05-13 07:00 |
Regulatory News Service
PR Valacyclovir AFT and QliniQ_En.pdf
|
English | 144.5 KB | |
2025-05-13 07:00 |
Regulatory News Service
PR Valacyclovir AFT and QliniQ_fr.pdf
|
French | 187.9 KB | |
2025-05-09 22:00 |
Annual Report
Rapport de Gestion.pdf
|
French | 3.8 MB | |
2025-05-09 22:00 |
Proxy Solicitation & Information Statements
20250425Hyloris Pharmaceuticals SA - Vote by letter form (EN)_GM 10 June 2025.p…
|
English | 243.6 KB | |
2025-05-09 22:00 |
Annual Audited Financial Statements
Audit report Conso_FR.pdf
|
French | 265.0 KB | |
2025-05-09 22:00 |
Proxy Solicitation & Information Statements
20250425Hyloris Pharmaceuticals SA - Proxy (EN)_GM 10 June 2025.pdf
|
English | 245.9 KB | |
2025-05-09 22:00 |
Annual Report
20250506 HYLORIS_RA24_FR final.pdf
|
French | 5.1 MB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
2023-06-13 | Aichhorn Dietmar | Executive member | Buy | 12,500 | 144,375.00 EUR |
2023-06-13 | Vandebroek Jean-Luc | Executive member | Buy | 6,000 | 69,300.00 EUR |
2022-04-14 | Van der Elst Koenraad | Executive member | Sell | 3,312 | 56,466.40 EUR |
2022-03-22 | Aichhorn Dietmar | Executive member | Buy | 20,000 | 347,000.00 EUR |
2022-03-22 | Vandebroek Jean-Luc | Board | Buy | 3,000 | 52,050.00 EUR |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
1NKEMIA | Spain | IKM | |
![]() |
2cureX AB | Sweden | 2CUREX | |
![]() |
4SC AG | Germany | VSC | |
![]() |
Abera Bioscience AB | Sweden | ABERA | |
![]() |
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
![]() |
AB Science | France | AB | |
![]() |
Acticor Biotech | France | ALACT | |
![]() |
Active Biotech | Sweden | ACTI | |
![]() |
AcuCort AB | Sweden | ACUC |